Xylem (NYSE: XYL) insider transactions
In the twelve months to 10 November 2026, executives and directors of Xylem reported 1 open-market sale of 4,269 shares ($501,437) and 2 open-market purchases of 12,210 shares ($1.1m), by 3 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 29 October 2026 | Koch D Christian | Director | Open-market purchase | +11,000 | $89.60 | 12,247 | Form 4 |
| 21 October 2026 | Emmerich Meredith | EVP & President, MCS | Shares withheld for tax | −837 | $106.35 | 4,610 | Form 4 |
| 1 October 2026 | McShane Geri-Michelle | SVP, CAO | Grant or award | +4,225 | — | 7,830 | Form 4 |
| 1 September 2026 | Johnston Joseph Patrick | EVP & President, AW | Grant or award | +645 | — | 2,285 | Form 4 |
| 1 September 2026 | van der Berg Andrea Michele | EVP & Chief Financial Officer | Grant or award | +1,693 | — | 10,691 | Form 4 |
| 13 August 2026 | Koch D Christian | Director | Grant or award | +1,247 | $120.27 | 1,247 | Form 4 |
| 14 May 2026 | Ellis Earl Ray | Director | Grant or award | +1,711 | $116.88 | 6,038 | Form 4 |
| 14 May 2026 | Friel Robert F | Director | Grant or award | +2,481 | $116.88 | 38,706 | Form 4 |
| 14 May 2026 | Glatch Lisa | Director | Grant or award | +1,711 | $116.88 | 6,874 | Form 4 |
| 14 May 2026 | Harker Victoria D | Director | Grant or award | +1,711 | $116.88 | 18,586 | Form 4 |
| 14 May 2026 | Morelli Mark D | Director | Grant or award | +1,711 | $116.88 | 8,026 | Form 4 |
| 14 May 2026 | Peribere Jerome A | Director | Grant or award | +1,711 | $116.88 | 5,747 | Form 4 |
| 14 May 2026 | Tretikov Lila | Director | Grant or award | +1,711 | $116.88 | 10,406 | Form 4 |
| 14 May 2026 | Yadav Uday | Director | Grant or award | +1,711 | $116.88 | 10,337 | Form 4 |
| 7 May 2026 | McShane Geri-Michelle | SVP, CAO | Option exercise | −3,147 | $86.76 | 7,874 | Form 4 |
| 7 May 2026 | McShane Geri-Michelle | SVP, CAO | Open-market sale | −4,269 | $117.46 | 3,605 | Form 4 |
| 4 May 2026 | Peribere Jerome A | Director | Open-market purchase | +1,210 | $116.61 | 27,209 | Form 4 |
| 5 March 2026 | Aulick Rodney | EVP & President, WSS | Shares withheld for tax | −234 | $126.19 | 73,683 | Form 4 |
| 5 March 2026 | Cho Albert | EVP, Strategy | Shares withheld for tax | −177 | $126.19 | 16,411 | Form 4 |
| 5 March 2026 | Cozad Stacy | EVP & Chief Legal Officer | Shares withheld for tax | −70 | $126.19 | 2,233 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Xylem page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.